Chile
IctioBiotic SpA, established in 2018 and headquartered in Chile, is advancing innovation in the biotechnology sector with its distinctive approach to aquaculture. Operating under the slogan, "For a more sustainable aquaculture," the company positions itself at the intersection of Biotechnology, Health and Wellness, Life Sciences, and Waste Solution industries.
Dedicated to introducing environmentally friendly advancements, IctioBiotic specializes in creating novel oral biotherapeutics, primarily targeting the aquaculture industry to foster sustainability and reduce reliance on antibiotics. Their flagship innovation leverages a proprietary platform of modified food grade microbes that articulate recombinant proteins such as cytokines and antigens, functioning as immunostimulants and vaccines to bolster the health of fish populations.
This pioneering solution not only aims to enhance the sanitary conditions of fish farms but also supports the production of sustainable protein sources for human consumption. Despite the lack of recent investment activity, IctioBiotic presents a promising opportunity with its unique technological propositions that align with increasing global demands for ecological and health-conscious aquaculture solutions.
